Drug industry unlikely to achieve their sales forecast.

Most of local pharmaceutical companies seem hardly to achieve their sales target this year mainly because of the KFDA's delayed approval for the applications of new products stemming from the bio equivalency scandals and the parliamentary inspection of the government administration.

Especially the new product applications filed after March this year have not been approved.

The industry a...